HIVE Blockchain Ownership
| HIVE Stock | USD 4.07 0.02 0.49% |
Shares in Circulation | First Issued 2010-06-30 | Previous Quarter 114.1 M | Current Value 118.6 M | Avarage Shares Outstanding 56.3 M | Quarterly Volatility 81.2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
HIVE |
HIVE Stock Ownership Analysis
About 23.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. HIVE Blockchain Tech recorded a loss per share of 0.13. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 24th of May 2022. HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. HIVE Blockchain Technologies Ltd. was incorporated in 1987 and is headquartered in Vancouver, Canada. Hive Blockchain operates under Capital Markets classification in the United States and is traded on NASDAQ Exchange. It employs 18 people. To learn more about HIVE Blockchain Technologies call Aydin Kilic at 604-664-1078 or check out https://hivedigitaltechnologies.com.Besides selling stocks to institutional investors, HIVE Blockchain also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different HIVE Blockchain's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align HIVE Blockchain's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
HIVE Blockchain Quarterly Liabilities And Stockholders Equity |
|
Less than 1% of HIVE Blockchain Technologies are currently held by insiders. Unlike HIVE Blockchain's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against HIVE Blockchain's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of HIVE Blockchain's insider trades
HIVE Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as HIVE Blockchain is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HIVE Blockchain Technologies backward and forwards among themselves. HIVE Blockchain's institutional investor refers to the entity that pools money to purchase HIVE Blockchain's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-06-30 | 465.2 K | Bank Of America Corp | 2024-06-30 | 452 K | Group One Trading, Lp | 2024-09-30 | 393.4 K | First Trust Advisors L.p. | 2024-09-30 | 342.2 K | Charles Schwab Investment Management Inc | 2024-09-30 | 325.2 K | Cubist Systematic Strategies, Llc | 2024-09-30 | 222.4 K | Federation Des Caisses Desjardins Du Quebec | 2024-09-30 | 172.2 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 162.8 K | Xtx Topco Ltd | 2024-09-30 | 147.9 K | Tidal Investments Llc. | 2024-09-30 | 4 M | Van Eck Associates Corporation | 2024-06-30 | 3.9 M |
HIVE Blockchain Tech Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific HIVE Blockchain insiders, such as employees or executives, is commonly permitted as long as it does not rely on HIVE Blockchain's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases HIVE Blockchain insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ritchie John over a week ago Disposition of 3675 shares by Ritchie John of HIVE Blockchain at 3.66 subject to Rule 16b-3 | ||
Ritchie John over a month ago Acquisition by Ritchie John of 4671 shares of HIVE Blockchain subject to Rule 16b-3 | ||
Lightspeed Venture Partners Vii, L.p. over a month ago Acquisition by Lightspeed Venture Partners Vii, L.p. of 19146 shares of HIVE Blockchain subject to Rule 16b-3 | ||
Ritchie John over two months ago Disposition of 1616 shares by Ritchie John of HIVE Blockchain at 5.09 subject to Rule 16b-3 | ||
Ritchie John over three months ago Disposition of 1616 shares by Ritchie John of HIVE Blockchain at 5.09 subject to Rule 16b-3 | ||
Christopher Schaepe over six months ago Acquisition by Christopher Schaepe of 19146 shares of HIVE Blockchain subject to Rule 16b-3 |
HIVE Blockchain Outstanding Bonds
HIVE Blockchain issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HIVE Blockchain Tech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HIVE bonds can be classified according to their maturity, which is the date when HIVE Blockchain Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
HIVE Blockchain Corporate Filings
6K | 27th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 5th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 3rd of October 2024 Other Reports | ViewVerify | |
| 30th of September 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether HIVE Blockchain Tech is a strong investment it is important to analyze HIVE Blockchain's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HIVE Blockchain's future performance. For an informed investment choice regarding HIVE Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HIVE Blockchain Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HIVE Blockchain. If investors know HIVE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HIVE Blockchain listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.217 | Earnings Share (0.13) | Revenue Per Share 1.171 | Quarterly Revenue Growth (0.01) | Return On Assets (0.08) |
The market value of HIVE Blockchain Tech is measured differently than its book value, which is the value of HIVE that is recorded on the company's balance sheet. Investors also form their own opinion of HIVE Blockchain's value that differs from its market value or its book value, called intrinsic value, which is HIVE Blockchain's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HIVE Blockchain's market value can be influenced by many factors that don't directly affect HIVE Blockchain's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HIVE Blockchain's value and its price as these two are different measures arrived at by different means. Investors typically determine if HIVE Blockchain is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HIVE Blockchain's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.